Quidel Corporation (QDEL): Price and Financial Metrics

QDEL POWR Grades

• QDEL scores best on the Value dimension, with a Value rank ahead of 95.08% of US stocks.
• The strongest trend for QDEL is in Growth, which has been heading up over the past 179 days.
• QDEL ranks lowest in Momentum; there it ranks in the 5th percentile.

QDEL Stock Summary

• Quidel Corp's stock had its IPO on March 3, 1992, making it an older stock than 81.48% of US equities in our set.
• QDEL's current price/earnings ratio is 6.72, which is higher than only 12.61% of US stocks with positive earnings.
• QDEL's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 17.81% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to Quidel Corp are PLAB, SMWB, APPN, BDR, and OSUR.
• Visit QDEL's SEC page to see the company's official filings. To visit the company's web site, go to www.quidel.com.

QDEL Valuation Summary

• QDEL's price/earnings ratio is 6; this is 83.56% lower than that of the median Healthcare stock.
• QDEL's price/earnings ratio has moved up 24.7 over the prior 243 months.
• Over the past 243 months, QDEL's EV/EBIT ratio has gone up 28.7.

Below are key valuation metrics over time for QDEL.

QDEL Growth Metrics

Its year over year cash and equivalents growth rate is now at 801.95%.
• The 4 year net income to common stockholders growth rate now stands at 753.4%.
• Its 4 year revenue growth rate is now at 204.51%.

QDEL's revenue has moved up $1,197,441,000 over the prior 34 months.

The table below shows QDEL's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	1,698.551	805.869	704.226
2021-09-30	1,870.887	923.623	883.039
2021-06-30	1,837.209	917.019	899.555
2021-03-31	1,862.353	1,154.04	948.134
2020-12-31	1,661.668	629.763	810.287
2020-09-30	1,004.643	238.356	370.783

QDEL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• QDEL has a Quality Grade of B, ranking ahead of 85.03% of graded US stocks.
• QDEL's asset turnover comes in at 1.046 -- ranking 21st of 680 Pharmaceutical Products stocks.
• SYRS, ONVO, and SESN are the stocks whose asset turnover ratios are most correlated with QDEL.

The table below shows QDEL's key quality metrics over time.